Jim Cramer, the host of Mad Money, recently shared his thoughts on the upcoming earnings season, emphasizing that investors should tread carefully and avoid making any big moves.

Shares of Mind Medicine Inc. climbed over 2% on Tuesday afternoon, on track to break a two-session losing streak, as Evercore ...

Fintel reports that on January 28, 2025, Evercore ISI Group initiated coverage of Mind Medicine (NasdaqGS:MNMD) with a ...

ConocoPhillips (COP) stock saw a modest uptick, ending the day at $102.69 which represents a slight increase of $0.86 or 0.84% from the prior close of $101.83. The stock opened at $102.45 and touched ...

Evercore ISI added Sherwin-Williams Company (NYSE: SHW) to its Tactical Outperform (TAP) List ahead of the company's fourth-quarter earnings, citing an improving ...

The release of DeepSeek’s AI model sparked not only market turmoil but also a flurry of activity in Washington, where the ...

In a report released yesterday, Michael Binetti from Evercore ISI maintained a Buy rating on Tapestry (TPR – Research Report), with a price ...

Evercore ISI raised the firm’s price target on Lululemon (LULU) to $495 from $440 and keeps an Outperform rating on the shares, which have also ...

Estee Lauder is reviewing its portfolio of beauty brands, which could potentially lead to the sale of some of the labels, as ...

Estée Lauder Cos is reviewing its portfolio of beauty brands, people with knowledge of the matter said, as the cosmetics ...

We recently published a list of Top 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where ...

Akero Therapeutics reports positive mid-stage data for efruxifermin - its candidate treatment for cirrhosis. Akero stock rallied over 100%.